Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cash boost for SpectRx' cervical cancer detector:

This article was originally published in Clinica

Executive Summary

SpectRx is to accelerate its programme to develop a non-invasive cervical cancer detection device, after receiving a $1.4m grant award from the US National Cancer Institute. The grant will be primarily used to help fund the pivotal clinical trials necessary for approval to market the biophotonic device in the US. The Norcross, Georgia firm said that the trials would start within 90 days.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061319

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel